中興通訊(00763.HK)擬出資不超4億元認購紅土湛盧二期基金份額
格隆匯4月25日丨中興通訊(00763.HK)公吿,公司擬作為有限合夥人出資不超過4億元人民幣認購深圳市紅土湛盧二期股權投資合夥企業(有限合夥)(暫定名,以工商核准為準,以下簡稱“紅土湛盧二期基金”)份額。
基金規模為不超過10億元人民幣(最終以實際募集金額為準)。首期募集資金3億元人民幣,惠州紅土、深創投、中興通訊共同認繳出資3億元人民幣,出資方式均為貨幣。
紅土湛盧二期基金主要投資於成長期階段項目,重點關注成長期的ICT企業。中興通訊出資認購紅土湛盧二期基金,依託專業投資機構的經驗和資本力量,獲取更大的投資收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.